Yale Medicine School: Convalescent Plasma Therapy Provides Limited Success in Treating COVID-19
January 15, 2022
January 15, 2022
NEW HAVEN, Connecticut, Jan. 15 (TNSJou) -- Yale School of Medicine issued the following news:
Convalescent plasma therapy was one of the first treatments available in the battle against COVID-19. But since the therapy's emergency use authorization by the Food and Drug Administration in August 2020, its supposed benefits have been met with scrutiny by some researchers.
To investigate the success of convalescent plasma therapy in reducing the severity and mortality . . .
Convalescent plasma therapy was one of the first treatments available in the battle against COVID-19. But since the therapy's emergency use authorization by the Food and Drug Administration in August 2020, its supposed benefits have been met with scrutiny by some researchers.
To investigate the success of convalescent plasma therapy in reducing the severity and mortality . . .